Primary pulmonary artery sarcoma is a rare cardiac tumor with a dismal prognosis without
surgical therapy. It is often confused with the more common chronic pulmonary emboli
which may delay the appropriate diagnosis or lead to suboptimal surgery. The objective
of this study was to evaluate the short and long-term survival and local recurrence
rate of pulmonary artery sarcoma cases operated on at our institution using an anatomic
resection approach for the pulmonary trunk and main pulmonary arteries rather than
endarterectomy. We searched our prospectively collected cardiac tumor database for
cases of primary pulmonary sarcoma operated at our institution between June 2000 and
September 2018 and followed until January 3, 2021. We used an anatomic resection and replacement technique for involved pulmonary root
and main pulmonary arteries with endarterectomy used only for disease distal to the
first arterial branch when lung preservation was possible. The primary endpoints for
our study were survival from the time of initial diagnosis and survival from the time
of our surgery. Secondary endpoints were operative 30-day mortality and incidence
of local recurrence or metastatic disease. We identified 20 consecutive cases of surgical
resection of primary pulmonary sarcoma. The median age at surgery was 52.5 years (IQR
43.5–60.5). Complete pulmonary root resection and reconstruction using a pulmonary
homograft were needed in 16/20 (80%) of cases. All resections employed cardiopulmonary
bypass with cardioplegic arrest. A pneumonectomy was needed in 7/20 (35%) of patients.
A negative margin (R0) resection was achieved in 9 patients (45%) and margins were
microscopically positive (R1) on final pathology in 9 patients (45%). Two patients
(10%) had gross tumor (R2) at the resection margin. Operative mortality was 2/20 (10%).
Median survival was 2.8 years from diagnosis (95% CI 1.3–8.8) and 2.7 years from surgery
by our team (95% CI 0.8–5.9). Survival from first initial diagnosis at 1, 3, 5, and 10 years was 85.0%, 49.1%, 49.1%, and 16.4%. Survival
from our surgery by our team at 1, 3, 5, and 10 years was 70%, 48.8%, 41.8%, and 8.4%. Surgical
resection of primary pulmonary artery sarcoma with an approach utilizing an anatomic
resection of the pulmonary root and main pulmonary arteries when involved and pneumonectomy
or endarterectomy when there is disease distal to the first branch artery can be done
with a reasonable operative risk and long-term survival when compared to the natural
history of the disease.
Graphical Abstract

Graphical Abstract
Keywords
Abbreviations:
IQR (interquartile range), CT (computed tomography), CMR (cardiac magnetic resonance imaging), CPB (cardiopulmonary bypass), R0 (pathologically negative surgical margin), R1 (microscopically positive surgical margin), R2 (grossly positive surgical margin), CI (Confidence interval)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seminars in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Über primäre Neubildungen des Herzens.Virchows Arch path Anat. 1923. 1923; 245: 43-54
- Fibrosarcoma of the pulmonary artery, masquerading as pheochromocytoma.Am J Clin Pathol. 1960; 34: 146-154
- Surgical treatment of pulmonary artery sarcoma: A report of 17 cases.Pulm Circ. 2021; 112045894020986394
- Management of primary pulmonary artery sarcomas.Ann Thorac Surg. 2009; 87: 977-984
- Surgical treatment of cardiac and pulmonary sarcomas.Operative Techniques Thorac Cardiovas Surg. 2021; (In press)
- The “Texas Two-Step” procedure.J Thorac Cardiovasc Surg. 2018; 155: 285-287
- Survival outcomes in patients with primary cardiac sarcoma in the United States.J Thorac Cardiovasc Surg. 2020;
- Clinical features and surgical outcomes of pulmonary artery sarcoma.J Thorac Cardiovasc Surg. 2018; 155 (e1101): 1109-1115
- Clinical presentation and surgical treatment of primary pulmonary artery sarcoma.Interact Cardiovasc Thorac Surg. 2018; 26: 243-247
- Clinical characteristics and treatment outcomes of primary pulmonary artery sarcoma in Korea.J Korean Med Sci. 2016; 31: 1755-1760
- Primary pulmonary artery sarcoma: A close associate of pulmonary embolism-20-year observational analysis.J Thorac Dis. 2016; 8: 2592-2601
- Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma.Eur J Cardiothorac Surg. 2013; 43: 787-793
- Imaging and surgical treatment of primary pulmonary artery sarcoma.Int J Cardiovasc Imaging. 2019; 35: 1429-1433
- Primary cardiac malignancies: The need for a multidisciplinary approach and the role of the cardio-oncologist.J Am Coll Cardiol. 2020; 75: 2348-2351
- Improved outcomes with the evolution of a neoadjuvant chemotherapy approach to right heart sarcoma.Ann Thorac Surg. 2017; 104: 90-96
Article info
Publication history
Published online: November 03, 2021
Footnotes
Funding: There was no funding source for this study.
Conflicts of Interest: The authors have nothing to disclose.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Commentary: Improving Surgical Outcomes for Pulmonary Artery Sarcoma: The Challenge RemainsSeminars in Thoracic and Cardiovascular SurgeryVol. 35Issue 1
- PreviewPrimary pulmonary artery sarcoma (PAS) is a rare thoracic tumor with a dismal prognosis.1 Since the report of Mandelstramm in 1923,2 there have been very few case series with more than 10 patients.3,4 Because of this, the clinical features, diagnostic modalities, surgical approaches, and chemotherapy/radiotherapy remain controversial.5,6
- Full-Text
- Preview
- Commentary: “It's a Heartache 2.0″Seminars in Thoracic and Cardiovascular SurgeryVol. 35Issue 1
- PreviewIn a recent editorial “It's a Heartache,”1 the Houston Methodist and MD Anderson Cancer Institute's surgical experience with 122 primary cardiac sarcomas (PCS) patients2 was likened to the verse “It's Nothing But a Heartache” from the 1977 Bonnie Tyler release It's A Heartache.1 Consequently, this review of the Primary Pulmonary Artery Sarcoma (PPAS) resection cohort from the same institution is entitled “It's A Heartache 2.0″ as it summarizes a sub-group from the initial report.
- Full-Text
- Preview